arrow
L

Laura V. Milko

University of North Carolina at Chapel Hill
H指数:20
被引数:2,665

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Feasibility and clinical utility of expanded genomic newborn screening in the Early Check program

Cope, H.L.; Jalazo, E.R.; Berg, J.S.; Sullivan, J.A.; Kucera, K.S.; Shone, S.M.; Frawley, H.E.; Gwaltney, A.Y.; Forsythe, A.N.; Migliore, B.A.; et al. 扩展基因组新生儿筛查在Early Check计划中的可行性与临床应用价值。Nat. Med. 2025, 31, 3762–3771. [Google Scholar] [CrossRef] [PubMed]

2025-09-050
OAAI
A systematic framework for selecting gene-condition pairs for inclusion in newborn sequencing panels: Early Check implementation
2024-12-012
PRE
Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project

新生儿筛查的基因组测序: NC NEXUS项目的结果

2020-10-0178
OAAI
An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn Screening
2019-06-0158
OAAI
Development of Clinical Domain Working Groups for the Clinical Genome Resource (ClinGen): lessons learned and plans for the future

临床基因组资源 (ClinGen) 临床领域工作组的发展: 经验教训和未来计划

2019-04-0117
OAAI
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes
2019-02-01308
OAAI
Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel

PTEN变体治疗的基因特异性标准: ClinGen PTEN专家小组的建议

2018-10-11116
OAAI
ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation

ClinGen变体管理专家小组的经验和疾病的标准化过程以及ACMG/AMP序列变体解释指南的基因水平规范

2018-10-11137
OAAI
Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource
2017-06-01420
OAAI
Newborn Sequencing in Genomic Medicine and Public Health

基因组医学和公共卫生中的新生儿测序

2017-02-01183
OAAI
A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation
2016-12-0183
OAAI